Forward Pharma A/S
Aveo Pharmaceuticals loses position in The Baupost Group
Seth Klarman’s The Baupost Group sold its stake in Aveo Pharmaceuticals (AVEO), according to a 13G filing in January.
Baupost discloses stake in Paratek Pharmaceuticals
Seth Klarman’s The Baupost Group added a 12.04% stake in Paratek Pharmaceuticals, Inc. (PRTK), according to a 13G filing in December.
Forward Pharma: One of Baupost’s new positions
Seth Klarman’s The Baupost Group added a 11.72% stake in Forward Pharma (FWP). A November 13G filing shows the fund owns 5,367,300 Forward Pharma shares.
Baupost nearly doubles position in Cheniere Energy
In its 13G filing in January, The Baupost Group upped its stake in Cheniere Energy (LNG), giving it 10.01% stake in LNG and nearly doubling its 3Q14 filing.